Facebook Twitter Youtube
  • Home
  • Find an Article
    • Volume 30 – 2025 Articles
      • Number 4: JUL – AUG 2025
      • Number 3: MAY – JUN 2025
      • Number 2: MAR – APR 2025
      • Number 1: JAN – FEB 2025
    • Volume 29 – 2024 Articles
      • Number 6: NOV – DEC 2024
      • Number 5: SEP – OCT 2024
      • Number 4: JUL – AUG 2024
      • Number 3: MAY – JUN 2024
      • Number 2: MAR – APR 2024
      • Number 1: JAN – FEB 2024
    • Volume 28 – 2023 Articles
      • Number 6: NOV-DEC 2023
      • Number 5: SEP-OCT 2023
      • Number 4: JUL-AUG 2023
      • Number 3: MAY-JUN 2023
      • Number 2: MAR-APR 2023
      • Number 1: JAN-FEB 2023
    • Volume 27 – 2022 Articles
      • Number 6: NOV-DEC 2022
      • Number 5: SEP-OCT 2022
      • Number 4: JUL-AUG 2022
      • Number 3: MAY-JUN 2022
      • Number 2: MAR-APR 2022
      • Number 1: JAN-FEB 2022
    • Volume 26 – 2021 Articles
      • Number 6: NOV-DEC 2021
      • Number 5: SEP-OCT 2021
      • Number 4: JUL-AUG 2021
      • Number 3: MAY-JUN 2021
      • Number 2: MAR-APR 2021
      • Number 1: JAN-FEB 2021
    • Volume 25 – 2020 Articles
      • Number 5: NOV-DEC 2020
      • Number 4: SEP-OCT 2020
      • Special Edition – June 2020
      • Number 3: MAY-JUN 2020
      • Number 2: MAR-APR 2020
      • Number 1: JAN-FEB 2020
    • OLDER ARCHIVES
  • STL Editions
    • Dermatology
      • Dermatology Edition
      • STL Derm Supplement
    • Family Practice
    • Pharmacist
  • Conditions
    • Acne
    • Eczema
    • Psoriasis
    • Skin Cancer
    • Fungal Infections
    • Rosacea
    • Aging Skin
    • Cosmetic Dermatology
  • Contributors
  • Videos
  • Downloads
Search
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.
Skin Therapy Letter Skin Therapy Letter
Skin Therapy Letter Skin Therapy Letter
  • Home
  • Find an Article
    • Volume 30 – 2025 Articles
      • Number 4: JUL – AUG 2025
      • Number 3: MAY – JUN 2025
      • Number 2: MAR – APR 2025
      • Number 1: JAN – FEB 2025
    • Volume 29 – 2024 Articles
      • Number 6: NOV – DEC 2024
      • Number 5: SEP – OCT 2024
      • Number 4: JUL – AUG 2024
      • Number 3: MAY – JUN 2024
      • Number 2: MAR – APR 2024
      • Number 1: JAN – FEB 2024
    • Volume 28 – 2023 Articles
      • Number 6: NOV-DEC 2023
      • Number 5: SEP-OCT 2023
      • Number 4: JUL-AUG 2023
      • Number 3: MAY-JUN 2023
      • Number 2: MAR-APR 2023
      • Number 1: JAN-FEB 2023
    • Volume 27 – 2022 Articles
      • Number 6: NOV-DEC 2022
      • Number 5: SEP-OCT 2022
      • Number 4: JUL-AUG 2022
      • Number 3: MAY-JUN 2022
      • Number 2: MAR-APR 2022
      • Number 1: JAN-FEB 2022
    • Volume 26 – 2021 Articles
      • Number 6: NOV-DEC 2021
      • Number 5: SEP-OCT 2021
      • Number 4: JUL-AUG 2021
      • Number 3: MAY-JUN 2021
      • Number 2: MAR-APR 2021
      • Number 1: JAN-FEB 2021
    • Volume 25 – 2020 Articles
      • Number 5: NOV-DEC 2020
      • Number 4: SEP-OCT 2020
      • Special Edition – June 2020
      • Number 3: MAY-JUN 2020
      • Number 2: MAR-APR 2020
      • Number 1: JAN-FEB 2020
    • OLDER ARCHIVES
  • STL Editions
    • Dermatology
      • Dermatology Edition
      • STL Derm Supplement
    • Family Practice
    • Pharmacist
  • Conditions
    • Acne
    • Eczema
    • Psoriasis
    • Skin Cancer
    • Fungal Infections
    • Rosacea
    • Aging Skin
    • Cosmetic Dermatology
  • Contributors
  • Videos
  • Downloads
Ooops... Error 404
Sorry, but the page you are looking for doesn't exist.
You can go to the HOMEPAGE

OUR LATEST POSTS

Supplement

Protected: What’s New in Pre-Aging Topical Modalities: The Clinical Efficacy of Acetyl Dipeptide-31 Amide

Psoriasis

Real World Canadian Case Series: Use of Tildrakizumab for Moderate-to-Severe Psoriasis

Lebrikizumab concept
Atopic Dermatitis

Lebrikizumab for Moderate-to-Severe Atopic Dermatitis

Nanodermatology concept, skin DNA
Dermatology

Nanodermatology

image with pills and medical devices on yellow background
Dermatology

Update on Drugs & Devices: July-August 2025

image of skin with medecine working through it
Atopic Dermatitis

Use of Nemolizumab in the Treatment of Prurigo Nodularis and Atopic Dermatitis

  • Facebook
  • X
  • Mail
  • Disclaimer
  • Privacy Policy
  • Medical Advisory
© SkinTherapyLetter. All rights reserved.